- Home
- SNY vs BBVA Comparison
SNY vs BBVA Comparison
Compare SNY & BBVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- BBVA
- Stock Information
- Founded
- SNY 1994
- BBVA 1857
- Country
- SNY France
- BBVA Spain
- Employees
- SNY N/A
- BBVA N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- BBVA Commercial Banks
- Sector
- SNY Health Care
- BBVA Finance
- Exchange
- SNY Nasdaq
- BBVA Nasdaq
- Market Cap
- SNY 116.1B
- BBVA 103.6B
- IPO Year
- SNY N/A
- BBVA N/A
- Fundamental
- Price
- SNY $51.00
- BBVA $19.91
- Analyst Decision
- SNY Buy
- BBVA Buy
- Analyst Count
- SNY 4
- BBVA 1
- Target Price
- SNY $61.50
- BBVA N/A
- AVG Volume (30 Days)
- SNY 3.1M
- BBVA 1.7M
- Earning Date
- SNY 10-24-2025
- BBVA 10-29-2025
- Dividend Yield
- SNY 3.11%
- BBVA 3.13%
- EPS Growth
- SNY 105.93
- BBVA 16.75
- EPS
- SNY 8.67
- BBVA 2.07
- Revenue
- SNY $53,890,648,839.00
- BBVA $36,849,089,843.00
- Revenue This Year
- SNY $1.40
- BBVA $16.73
- Revenue Next Year
- SNY $6.67
- BBVA $3.20
- P/E Ratio
- SNY $11.67
- BBVA $9.70
- Revenue Growth
- SNY N/A
- BBVA 4.59
- 52 Week Low
- SNY $44.62
- BBVA $9.23
- 52 Week High
- SNY $60.12
- BBVA $20.16
- Technical
- Relative Strength Index (RSI)
- SNY 59.74
- BBVA 59.64
- Support Level
- SNY $49.62
- BBVA $19.44
- Resistance Level
- SNY $52.20
- BBVA $20.03
- Average True Range (ATR)
- SNY 0.66
- BBVA 0.42
- MACD
- SNY 0.19
- BBVA 0.08
- Stochastic Oscillator
- SNY 72.42
- BBVA 89.11
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
About BBVA Banco Bilbao Vizcaya Argentaria S.A.
Despite its Spanish origins, BBVA generates only around a quarter of its profits in Spain. We expect that on a normalised basis, BBVA's market-leading Mexican bank should contribute half of its earnings, while its Turkish operation should account for another 15%. The balance of BBVA's earnings comes from smaller operations in South America. BBVA is overwhelmingly a retail and commercial bank, with corporate and investment banking forming a minor part of the overall business. BBVA also offers insurance and investment products through its banking networks.